Slow Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-21,584
| Closed | -$310K | – | 123 |
|
2024
Q4 | $310K | Sell |
21,584
-94,756
| -81% | -$1.36M | 0.04% | 115 |
|
2024
Q3 | $2.63M | Buy |
116,340
+10,814
| +10% | +$244K | 0.4% | 77 |
|
2024
Q2 | $2.05M | Buy |
105,526
+17,761
| +20% | +$345K | 0.33% | 85 |
|
2024
Q1 | $3.29M | Buy |
87,765
+23,749
| +37% | +$891K | 0.53% | 62 |
|
2023
Q4 | $3.58M | Sell |
64,016
-1,300
| -2% | -$72.7K | 0.62% | 49 |
|
2023
Q3 | $2.69M | Sell |
65,316
-3,604
| -5% | -$149K | 0.49% | 63 |
|
2023
Q2 | $3.85M | Sell |
68,920
-3,079
| -4% | -$172K | 0.67% | 36 |
|
2023
Q1 | $4.02M | Buy |
71,999
+18,352
| +34% | +$1.02M | 0.75% | 34 |
|
2022
Q4 | $1.95M | Sell |
53,647
-5,285
| -9% | -$193K | 0.44% | 79 |
|
2022
Q3 | $1.68M | Sell |
58,932
-1,560
| -3% | -$44.4K | 0.36% | 85 |
|
2022
Q2 | $2.74M | Buy |
60,492
+18,702
| +45% | +$846K | 0.66% | 44 |
|
2022
Q1 | $3.18M | Buy |
41,790
+24,595
| +143% | +$1.87M | 0.59% | 43 |
|
2021
Q4 | $2.56M | Buy |
17,195
+8,019
| +87% | +$1.19M | 0.44% | 83 |
|
2021
Q3 | $1.34M | Buy |
9,176
+562
| +7% | +$81.8K | 0.24% | 120 |
|
2021
Q2 | $1.69M | Buy |
8,614
+2,562
| +42% | +$502K | 0.32% | 112 |
|
2021
Q1 | $1.1M | Buy |
6,052
+1,636
| +37% | +$296K | 0.24% | 130 |
|
2020
Q4 | $626K | Buy |
4,416
+4,358
| +7,514% | +$618K | 0.15% | 135 |
|
2020
Q3 | $7K | Buy |
+58
| New | +$7K | ﹤0.01% | 253 |
|